B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: An ENTIRE–TIMI-23 substudy
Open Access
- 21 July 2004
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (2), 335-339
- https://doi.org/10.1016/j.jacc.2004.04.033
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial InfarctionCirculation, 2002
- Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunctionEuropean Heart Journal, 2000
- Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarctionHeart, 1999
- Plasma N-Terminal Pro–Brain Natriuretic Peptide and AdrenomedullinCirculation, 1998
- Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarctionJournal of the American College of Cardiology, 1996
- Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial InfarctionCirculation, 1996
- Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.Circulation, 1993
- Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarctionThe Lancet, 1993